Maccura Biotechnology Co.Ltd (SHE:300463)
11.03
+0.24 (2.22%)
Apr 8, 2026, 2:05 PM CST
SHE:300463 Market Cap
SHE:300463 has a market cap or net worth of 6.52 billion as of April 7, 2026. Its market cap has decreased by -21.98% in one year.
Market Cap
6.52B
Enterprise Value
6.87B
Revenue
2.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
11.03
Market Cap Chart
Since May 28, 2015, SHE:300463's market cap has decreased from 7.49B to 6.52B, a decrease of -12.87%. That is a compound annual growth rate of -1.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 6.52B | -3.57% |
| Dec 31, 2025 | 6.77B | -15.53% |
| Dec 31, 2024 | 8.01B | -13.22% |
| Dec 29, 2023 | 9.23B | -12.89% |
| Dec 30, 2022 | 10.60B | -34.77% |
| Dec 31, 2021 | 16.24B | -37.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dian Diagnostics Group | 11.12B |
| Amoy Diagnostics | 8.58B |
| Cowealth Medical China | 8.02B |
| Shanghai Runda Medical Technology | 7.40B |
| Beijing Strong Biotechnologies,Inc. | 6.89B |
| Thalys Medical Technology Group | 5.05B |
| SMO ClinPlus CO.,LTD. | 4.65B |
| Guangdong Hybribio Biotech | 4.19B |